ArticleJournal of clinical medicine2025
Effects of Empagliflozin and Dapagliflozin on Lipid Profiles and Atherogenic Risk Indices in Patients with Heart Failure and a History of CABG: First Evidence in the Literature.
Ilhan Ozgol et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.